PMID-sentid Pub_year Sent_text compound_name comp_offset prot_official_name organism prot_offset 10212222-8 1999 MLDG partially inhibited adhesion of K562 cells to fibronectin (5-10 mM) in contrast to RGDS peptide (IC50 = 3 mM), inhibiting completely at 10 mM. mldg 0-4 fibronectin 1 Homo sapiens 51-62 10926928-0 2000 Inhibitory effects of MLDG-containing heterodimeric disintegrins reveal distinct structural requirements for interaction of the integrin alpha 9beta 1 with VCAM-1, tenascin-C, and osteopontin. mldg 22-26 vascular cell adhesion molecule 1 Homo sapiens 156-162 10926928-0 2000 Inhibitory effects of MLDG-containing heterodimeric disintegrins reveal distinct structural requirements for interaction of the integrin alpha 9beta 1 with VCAM-1, tenascin-C, and osteopontin. mldg 22-26 tenascin C Homo sapiens 164-174 10926928-0 2000 Inhibitory effects of MLDG-containing heterodimeric disintegrins reveal distinct structural requirements for interaction of the integrin alpha 9beta 1 with VCAM-1, tenascin-C, and osteopontin. mldg 22-26 secreted phosphoprotein 1 Homo sapiens 180-191 24648940-7 2013 In addition, immunohistochemistry showed that although cWPROL and the mixture of lidocaine, dexamethasone and gentamycin (mLDG) induced levels of EGF and TGF-beta1 expression, there were differences between the two types of intervention. mldg 122-126 epidermal growth factor like 1 Rattus norvegicus 146-149 24648940-7 2013 In addition, immunohistochemistry showed that although cWPROL and the mixture of lidocaine, dexamethasone and gentamycin (mLDG) induced levels of EGF and TGF-beta1 expression, there were differences between the two types of intervention. mldg 122-126 transforming growth factor, beta 1 Rattus norvegicus 154-163